Kourtis, K.; Bourazana, A.; Xanthopoulos, A.; Skoularigkis, S.; Papadakis, E.; Patsilinakos, S.; Skoularigis, J.
Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention. Medicina 2024, 60, 166.
https://doi.org/10.3390/medicina60010166
AMA Style
Kourtis K, Bourazana A, Xanthopoulos A, Skoularigkis S, Papadakis E, Patsilinakos S, Skoularigis J.
Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention. Medicina. 2024; 60(1):166.
https://doi.org/10.3390/medicina60010166
Chicago/Turabian Style
Kourtis, Konstantinos, Angeliki Bourazana, Andrew Xanthopoulos, Spyridon Skoularigkis, Emmanouil Papadakis, Sotirios Patsilinakos, and John Skoularigis.
2024. "Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention" Medicina 60, no. 1: 166.
https://doi.org/10.3390/medicina60010166
APA Style
Kourtis, K., Bourazana, A., Xanthopoulos, A., Skoularigkis, S., Papadakis, E., Patsilinakos, S., & Skoularigis, J.
(2024). Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention. Medicina, 60(1), 166.
https://doi.org/10.3390/medicina60010166
